273 related articles for article (PubMed ID: 30904930)
21. Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing.
Joshi S; Andersen R; Jespersen B; Rittig S
Acta Paediatr; 2013 Sep; 102(9):844-56. PubMed ID: 23772861
[TBL] [Abstract][Full Text] [Related]
22. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
Gargah TT; Lakhoua MR
J Nephrol; 2011; 24(2):203-7. PubMed ID: 21319130
[TBL] [Abstract][Full Text] [Related]
24. Educational paper: the podocytopathies.
Büscher AK; Weber S
Eur J Pediatr; 2012 Aug; 171(8):1151-60. PubMed ID: 22237399
[TBL] [Abstract][Full Text] [Related]
25. Machine learning models for predicting steroid-resistant of nephrotic syndrome.
Ye Q; Li Y; Liu H; Mao J; Jiang H
Front Immunol; 2023; 14():1090241. PubMed ID: 36776850
[TBL] [Abstract][Full Text] [Related]
26. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
27. Steroid-resistant Nephrotic Syndrome in Children: A Mini-review on Genetic Mechanisms, Predictive Biomarkers and Pharmacotherapy Strategies.
Guo HL; Li L; Xu ZY; Jing X; Xia Y; Qiu JC; Ji X; Chen F; Xu J; Zhao F
Curr Pharm Des; 2021; 27(2):319-329. PubMed ID: 33138756
[TBL] [Abstract][Full Text] [Related]
28. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.
Stefanidis CJ; Querfeld U
Eur J Pediatr; 2011 Nov; 170(11):1377-83. PubMed ID: 21298518
[TBL] [Abstract][Full Text] [Related]
29. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
30. Treatment of steroid-resistant nephrotic syndrome in the genomic era.
Bensimhon AR; Williams AE; Gbadegesin RA
Pediatr Nephrol; 2019 Nov; 34(11):2279-2293. PubMed ID: 30280213
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
33. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D; Hodson E; Craig J
Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
[TBL] [Abstract][Full Text] [Related]
34. The podocyte as a direct target of immunosuppressive agents.
Schönenberger E; Ehrich JH; Haller H; Schiffer M
Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691
[TBL] [Abstract][Full Text] [Related]
35. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
36. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
37. Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome.
Siji A; Karthik KN; Pardeshi VC; Hari PS; Vasudevan A
BMC Med Genet; 2018 Nov; 19(1):200. PubMed ID: 30458709
[TBL] [Abstract][Full Text] [Related]
38. Management of steroid-resistant nephrotic syndrome in children and adolescents.
Tullus K; Webb H; Bagga A
Lancet Child Adolesc Health; 2018 Dec; 2(12):880-890. PubMed ID: 30342869
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
40. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Habashy D; Craig JC
Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
